Betmiga 25mg Tablet
By Betmiga
Rx
10 Tablet in a Strip

Composition
Mirabegron(25mg)

Manufacturer - Astellas Pharma Inc
Astellas Pharma India Pvt Ltd, 301, 3rd Floor, C and B Square, 127 Andheri Kurla Road, Chakala, Andheri East, Mumbai 400 069.

Expires on or after
July, 2025

liver
When taking Betmiga 25mg Tablet, it is important to be cautious if you have liver disease. Your doctor may need to adjust the dose to ensure safety and effectiveness. This medication is not recommended for individuals with severe liver disease. It is advised to consult with your doctor for proper guidance regarding the use of Betmiga 25mg Tablet if you have any liver issues.

kidney
Betmiga 25mg Tablet should be used carefully in patients with severe kidney disease. Adjusting the dose may be necessary. Consult your doctor before use.

alcohol
Caution is advised when using Betmiga 25mg Tablet with alcohol. It is recommended to consult your doctor.

driving
Betmiga 25mg Tablet typically does not impact driving ability.

pregnancy
Betmiga 25mg Tablet may not be safe to use during pregnancy. Animal studies suggest possible harm to the baby. Your doctor will consider the risks and benefits before prescribing. Please consult your doctor before using.

breastfeeding
Caution is advised when breastfeeding while using Betmiga 25mg Tablet as it may be unsafe. Limited data indicates that the drug could pass into breastmilk and potentially harm the baby.
Habit Forming | No |
Chemical Class | Anilide Derivative |
Therapeutic Class | UROLOGY |
Action Class | Selective beta 3-adrenoceptor agonist (Bladder) |
₹685.2
Inclusive of all taxes
Content verified by

Dr. Upasana Bhatia
MBBS - General Medicine
Last update on 11-Feb-2025